1. Home
  2. IMUX
  3. IMUX News

Latest Immunic Inc. (IMUX) News on January 5, 2025

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
IMUX

ACCESSWIRE

a month ago

Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing

Immunic, Inc. to Participate in Investor Conference in December
IMUX

PR Newswire

a month ago

Immunic, Inc. to Participate in Investor Conference in December

Insider Buys Additional US$100k In Immunic Stock
IMUX

Simply Wall St.

2 months ago

Insider Buys Additional US$100k In Immunic Stock

Immunic announces publication of IMU-856 data
IMUX

TipRanks

2 months ago

Immunic announces publication of IMU-856 data

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology
IMUX

PR Newswire

2 months ago

Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology

Immunic Inc (IMUX) Q3 2024 Earnings Call Highlights: Strategic Progress Amid Financial Challenges
IMUX

GuruFocus.com

2 months ago

Immunic Inc (IMUX) Q3 2024 Earnings Call Highlights: Strategic Progress Amid Financial Challenges

IMUX

Associated Press Finance

2 months ago

Immunic: Q3 Earnings Snapshot

Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update
IMUX

PR Newswire

2 months ago

Immunic, Inc. Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
IMUX

PR Newswire

2 months ago

Immunic, Inc. to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update

Immunic to Participate in Industry, Scientific and Investor Conferences in November
IMUX

PR Newswire

2 months ago

Immunic to Participate in Industry, Scientific and Investor Conferences in November

IMUX

MT Newswires

2 months ago

Immunic Shares Advance on Positive Outcome From Interim Analysis of Potential MS Treatment

IMUX

MT Newswires

2 months ago

Top Premarket Gainers

Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis
IMUX

PR Newswire

2 months ago

Immunic Announces Positive Outcome of Interim Analysis of Phase 3 ENSURE Program of Vidofludimus Calcium in Relapsing Multiple Sclerosis

We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully
IMUX

Simply Wall St.

3 months ago

We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully

IMUX

MT Newswires

3 months ago

Top Premarket Gainers

Immunic Inc (IMUX) Q2 2024 Earnings Call Highlights: Promising Clinical Data and Financial ...
IMUX

GuruFocus.com

3 months ago

Immunic Inc (IMUX) Q2 2024 Earnings Call Highlights: Promising Clinical Data and Financial ...

IMUX

MT Newswires

4 months ago

Immunic Says Initial Phase 2 Data Back Vidofludimus Calcium's Potential in Multiple Sclerosis

Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis
IMUX

PR Newswire

4 months ago

Immunic Presents Key Vidofludimus Calcium Data at the 40th Congress of ECTRIMS, Highlighting Its Therapeutic Potential in Multiple Sclerosis

Owning 39% shares,hedge funds owners seem interested in Immunic, Inc. (NASDAQ:IMUX),
IMUX

Simply Wall St.

4 months ago

Owning 39% shares,hedge funds owners seem interested in Immunic, Inc. (NASDAQ:IMUX),

Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome
IMUX

PR Newswire

4 months ago

Immunic Announces First Patient Enrolled in Investigator-Sponsored Phase 2 Clinical Trial of Vidofludimus Calcium in Patients with Post COVID Syndrome

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September
IMUX

PR Newswire

4 months ago

Immunic to Host Multiple Sclerosis R&D Day and Participate in Scientific and Investor Conferences in September

IMUX

MT Newswires

4 months ago

B. Riley Securities Initiates Immunic at Buy With $6 Price Target

IMUX

Associated Press Finance

5 months ago

Immunic: Q2 Earnings Snapshot

Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update
IMUX

PR Newswire

5 months ago

Immunic, Inc. Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update
IMUX

PR Newswire

5 months ago

Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec
IMUX

PR Newswire

5 months ago

Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Experienced Pharmaceutical Executive Simona Skerjanec

IMUX

MT Newswires

6 months ago

Immunic Names Jason Tardio as COO, Werner Gladdines as Chief Development Officer

Immunic Appoints Jason Tardio as Chief Operating Officer and President
IMUX

PR Newswire

6 months ago

Immunic Appoints Jason Tardio as Chief Operating Officer and President

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition
IMUX

Business Wire

7 months ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus
IMUX

GlobeNewswire

7 months ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23
IMUX

GlobeNewswire

7 months ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?
IMUX

Simply Wall St.

7 months ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May
IMUX

Reuters

7 months ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'
IMUX

AFP

7 months ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share
IMUX

GlobeNewswire

7 months ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed
IMUX

PR Newswire

7 months ago

Enduring role of 'treasuring the past' hailed

When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?
IMUX

Simply Wall St.

7 months ago

When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?

Immunic to Participate in Industry and Scientific Conferences in June
IMUX

PR Newswire

7 months ago

Immunic to Participate in Industry and Scientific Conferences in June

Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript
IMUX

Insider Monkey

8 months ago

Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript

We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully
IMUX

Simply Wall St.

8 months ago

We Think Immunic (NASDAQ:IMUX) Needs To Drive Business Growth Carefully

IMUX

Associated Press Finance

8 months ago

Immunic: Q1 Earnings Snapshot

Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update
IMUX

PR Newswire

8 months ago

Immunic, Inc. Reports First Quarter 2024 Financial Results and Provides Corporate Update

Immunic to Participate in Investor and Scientific Conferences in May
IMUX

PR Newswire

8 months ago

Immunic to Participate in Investor and Scientific Conferences in May

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal
IMUX

News Direct

8 months ago

Immunic Phase 2 EMPhASIS trial data highlighted in peer-reviewed neurology journal

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
IMUX

PR Newswire

8 months ago

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation
IMUX

PR Newswire

8 months ago

Immunic Announces Publication of Extended Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis in the Peer Reviewed Journal, Neurology® Neuroimmunology & Neuroinflammation

Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role
IMUX

News Direct

8 months ago

Immunic CEO Dr Daniel Vitt marks International Day of Immunology with discussion on its crucial role

With 44% ownership, Immunic, Inc. (NASDAQ:IMUX) has piqued the interest of hedge funds investors
IMUX

Simply Wall St.

9 months ago

With 44% ownership, Immunic, Inc. (NASDAQ:IMUX) has piqued the interest of hedge funds investors

Immunic to Host MS R&D Day and Participate in Investor Conferences in April
IMUX

PR Newswire

9 months ago

Immunic to Host MS R&D Day and Participate in Investor Conferences in April

Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month
IMUX

News Direct

9 months ago

Immunic CMO discusses complexities of multiple sclerosis to mark MS Awareness Month

Immunic secures key patent, boosting MS drug exclusivity and global IP strategy
IMUX

News Direct

9 months ago

Immunic secures key patent, boosting MS drug exclusivity and global IP strategy

Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States
IMUX

PR Newswire

10 months ago

Immunic Receives Notice of Allowance for Composition-of-Matter Patent of a Specific Polymorph of Vidofludimus Calcium in the United States

Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024
IMUX

News Direct

10 months ago

Immunic to reveal promising MS treatment data in two poster presentations at ACTRIMS Forum 2024

Immunic to Participate in Investor and Scientific Conferences in March
IMUX

PR Newswire

10 months ago

Immunic to Participate in Investor and Scientific Conferences in March

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024
IMUX

PR Newswire

10 months ago

Immunic Presents Data From Phase 2 CALLIPER and CALVID-1 Trials of Vidofludimus Calcium at the ACTRIMS Forum 2024

IMUX

GuruFocus.com

10 months ago

Immunic Inc (IMUX) Reports Year-End 2023 Financial Results

Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript
IMUX

Insider Monkey

10 months ago

Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript

Immunic reports successful 2023 and prepares for key 2025 milestones
IMUX

News Direct

10 months ago

Immunic reports successful 2023 and prepares for key 2025 milestones

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update
IMUX

PR Newswire

10 months ago

Immunic, Inc. Reports Year End 2023 Financial Results and Provides Corporate Update

Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update
IMUX

PR Newswire

a year ago

Immunic, Inc. to Announce Financial Results for the Year Ended December 31, 2023, and Provide Corporate Update

Immunic to Participate in Investor and Scientific Conferences in February
IMUX

PR Newswire

a year ago

Immunic to Participate in Investor and Scientific Conferences in February

IMUX

Business Wire

a year ago

Tillys Announces Leadership Transition

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors
IMUX

Barrons.com

a year ago

Freshpet, Tilly’s, and More Stocks See Action From Activist Investors

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
IMUX

GlobeNewswire

a year ago

Vaxart Receives $9.27 Million BARDA Project NextGen Award to Prepare for Phase 2b Clinical Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate

WeightWatchers Unveils “Beyond Hunger: Understanding Food Noise” Report Offering Insights Into the Experience of Ongoing, Intrusive Thoughts About Food
IMUX

GlobeNewswire

a year ago

WeightWatchers Unveils “Beyond Hunger: Understanding Food Noise” Report Offering Insights Into the Experience of Ongoing, Intrusive Thoughts About Food

IMUX

GlobeNewswire

a year ago

K. Hovnanian®️ Introduces Salerno Reserve, a New LOOKS Community in Stuart, FL

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity
IMUX

GlobeNewswire

a year ago

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

IMUX

Business Wire

a year ago

Solo Brands Announces Leadership Change to Support Its Next Chapter of Growth

Is Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) 3.2% ROE Worse Than Average?
IMUX

Simply Wall St.

a year ago

Is Syntec Optics Holdings, Inc.'s (NASDAQ:OPTX) 3.2% ROE Worse Than Average?

Immunic Highlights 2023 Accomplishments and Upcoming Milestones
IMUX

PR Newswire

a year ago

Immunic Highlights 2023 Accomplishments and Upcoming Milestones

Immunic, Inc. Announces Private Placement of up to $240 Million
IMUX

PR Newswire

a year ago

Immunic, Inc. Announces Private Placement of up to $240 Million

IMUX

Business Wire

a year ago

GAN Announces Launch of GAN Sports with Red Rock Resorts, Inc. under the STN Sports Brand

IMUX

Business Wire

a year ago

GAN Announces Changes to its Board of Directors

Zacks.com featured highlights Park Hotels & Resorts, Centene, Solo Brands and AZZ
IMUX

Zacks

a year ago

Zacks.com featured highlights Park Hotels & Resorts, Centene, Solo Brands and AZZ

Director Vincent Pagano Sells Shares of Hovnanian Enterprises Inc
IMUX

GuruFocus.com

a year ago

Director Vincent Pagano Sells Shares of Hovnanian Enterprises Inc

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
IMUX

GlobeNewswire

a year ago

BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

TPI and Nordex Extend and Expand Contract in Türkiye
IMUX

GlobeNewswire

a year ago

TPI and Nordex Extend and Expand Contract in Türkiye

Aeva to Showcase World’s First Automotive-Grade FMCW 4D LiDAR for Advanced Driver Assist and Autonomy in Production Vehicles at CES 2024
IMUX

Business Wire

a year ago

Aeva to Showcase World’s First Automotive-Grade FMCW 4D LiDAR for Advanced Driver Assist and Autonomy in Production Vehicles at CES 2024

Ondas Holdings Inc. (NASDAQ:ONDS) Shares Could Be 32% Above Their Intrinsic Value Estimate
IMUX

Simply Wall St.

a year ago

Ondas Holdings Inc. (NASDAQ:ONDS) Shares Could Be 32% Above Their Intrinsic Value Estimate

Asure Releases Third Quarter 2023 Results Showing 34% y/y Revenue Growth, Issues Preliminary FY 2024 Guidance
IMUX

ACCESSWIRE

a year ago

Asure Releases Third Quarter 2023 Results Showing 34% y/y Revenue Growth, Issues Preliminary FY 2024 Guidance

Penns Woods Bancorp (NASDAQ:PWOD) Is Due To Pay A Dividend Of $0.32
IMUX

Simply Wall St.

a year ago

Penns Woods Bancorp (NASDAQ:PWOD) Is Due To Pay A Dividend Of $0.32

Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago
IMUX

Simply Wall St.

a year ago

Shareholders in uniQure (NASDAQ:QURE) are in the red if they invested three years ago

TRX Gold Reports Year-End 2023 Results
IMUX

GlobeNewswire

a year ago

TRX Gold Reports Year-End 2023 Results

BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC
IMUX

GlobeNewswire

a year ago

BioAtla to Host Virtual KOL Event to Review IASLC Data on BA3011 in NSCLC

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
IMUX

GlobeNewswire

a year ago

Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)

Great week for Intevac, Inc. (NASDAQ:IVAC) institutional investors after losing 31% over the previous year
IMUX

Simply Wall St.

a year ago

Great week for Intevac, Inc. (NASDAQ:IVAC) institutional investors after losing 31% over the previous year

Natuzzi S.p.A.: Shareholder Letter and Financial Results 2023 Third Quarter Results
IMUX

Business Wire

a year ago

Natuzzi S.p.A.: Shareholder Letter and Financial Results 2023 Third Quarter Results

Natuzzi's (NYSE:NTZ) Returns On Capital Are Heading Higher
IMUX

Simply Wall St.

a year ago

Natuzzi's (NYSE:NTZ) Returns On Capital Are Heading Higher

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dosing Regimens in Multiple Sclerosis
IMUX

PR Newswire

a year ago

Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dosing Regimens in Multiple Sclerosis

IMUX

GlobeNewswire

a year ago

DayDayCook Announces Pricing of Initial Public Offering

7 Small-Cap Stocks Set to Soar as Interest Rates Stabilize
IMUX

InvestorPlace

a year ago

7 Small-Cap Stocks Set to Soar as Interest Rates Stabilize

Immunic focusing on business development during Q4
IMUX

News Direct

a year ago

Immunic focusing on business development during Q4

IMUX

Associated Press Finance

a year ago

Immunic: Q3 Earnings Snapshot

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update
IMUX

PR Newswire

a year ago

Immunic, Inc. Reports Third Quarter 2023 Financial Results and Provides Corporate Update

IMUX

Associated Press Finance

a year ago

Cadiz: Q3 Earnings Snapshot

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump
IMUX

Simply Wall St.

a year ago

Investors Still Aren't Entirely Convinced By Nutex Health Inc.'s (NASDAQ:NUTX) Revenues Despite 27% Price Jump

Braemar Hotels & Resorts Inc. (NYSE:BHR) Q3 2023 Earnings Call Transcript
IMUX

Insider Monkey

a year ago

Braemar Hotels & Resorts Inc. (NYSE:BHR) Q3 2023 Earnings Call Transcript

Where Food Comes From, Inc. Reports 2023 Third Quarter Financial Results
IMUX

GlobeNewswire

a year ago

Where Food Comes From, Inc. Reports 2023 Third Quarter Financial Results

Biodesix to Participate in Two Upcoming Investor Conferences in November
IMUX

Business Wire

a year ago

Biodesix to Participate in Two Upcoming Investor Conferences in November

IMUX

Business Wire

a year ago

GAN Announces Definitive Agreement to be Acquired by SEGA SAMMY CREATION

Share on Social Networks: